An Open-Label, Double-Treatment Group Study to Evaluate the Efficacy and Safety of Human Allogeneic Bone-Marrow- Derived Mesenchymal Stromal Cell Product StromaForte Compared With Hyaluronic Acid for the Treatment of Knee Osteoarthritis

NCT07542808 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Knee Arthritis Osteoarthritis

Interventions

OTHER: Mesenchymal Stem Cells (MSC)
OTHER: Hyaluronic Acid (HA)

Sponsor

Cellcolabs Clinical SPV Limited